This inventor holds 4 USPTO granted patents. Top assignee: Novartis Ag. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2016
Title: Felix Kollmer: Innovator in Macrocyclic Depsipeptides
Introduction
Felix Kollmer is a distinguished inventor based in Riehen, Switzerland. He has made significant contributions to the field of chemistry, particularly in the manufacture of macrocyclic depsipeptides. With a total of 4 patents to his name, Kollmer's work has advanced the understanding and production of these complex compounds.
Latest Patents
Kollmer's latest patents include innovative methods for the solution phase processes for the manufacture of macrocyclic depsipeptides. The first patent details a method for the chemical manufacture of depsipeptides of a specific formula, introducing new intermediates and their manufacturing processes. The second patent also focuses on similar methods, emphasizing the importance of these compounds in various applications.
Career Highlights
Felix Kollmer is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to explore and develop new chemical processes that have the potential to impact the pharmaceutical industry significantly.
Collaborations
Kollmer has collaborated with notable colleagues, including Murat Acemoglu and Heribert Hellstern. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.
Conclusion
Felix Kollmer's contributions to the field of macrocyclic depsipeptides exemplify the impact of innovative thinking in chemistry. His patents and work at Novartis AG continue to influence the development of new chemical processes and compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile